Commonwealth Equity Services, LLC Synlogic, Inc. Transaction History

Commonwealth Equity Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.0 - $4.39 $31,911 - $46,696	-10,637 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$2.2 - $5.05 $8,212 - $18,851	-3,733 Reduced 25.98%	10,637 $38,000
Q3 2020 Nov 05, 2020	BUY	$1.85 - $2.57 $26,584 - $36,930	14,370 New	14,370 $29,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.